UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Understanding the Mechanisms of Resistance in EGFR -Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy

International journal of molecular sciences, 2019-08, Vol.20 (16), p.3951

2019

Volltextzugriff (PDF)

The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide

Cancer treatment reviews, 2017-04, Vol.55, p.71-82

2017

Volltextzugriff (PDF)

Pathophysiology and pharmacological targets of VEGF in diabetic macular edema

Pharmacological research, 2016-01, Vol.103, p.149-157

2016

Volltextzugriff (PDF)

Implications of KRAS mutations in acquired resistance to treatment in NSCLC

Oncotarget, 2018-01, Vol.9 (5), p.6630-6643

2018

Volltextzugriff (PDF)

Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins

International journal of molecular sciences, 2017-01, Vol.18 (1), p.104-104

2017

Volltextzugriff (PDF)

Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma

Molecules (Basel, Switzerland), 2019-05, Vol.24 (9), p.1793

2019

Volltextzugriff (PDF)

Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma

Expert review of molecular diagnostics, 2020-01, Vol.20 (1), p.19-30

2020

Volltextzugriff (PDF)

Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma

Tumor biology, 2017-05, Vol.39 (5), p.1010428317701646-1010428317701646

2017

Volltextzugriff (PDF)

Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib

Breast (Edinburgh), 2022-12, Vol.66, p.157-161

2022

Volltextzugriff (PDF)

Abemaciclib pharmacology and interactions in the treatment of HR+/HER2- breast cancer: a critical review

Therapeutic advances in drug safety, 2024-01, Vol.15, p.20420986231224214-20420986231224214

2024

Volltextzugriff (PDF)

Pharmacological Basis of Breast Cancer Resistance to Therapies - An Overview

Anti-cancer agents in medicinal chemistry, 2022-02, Vol.22 (4), p.760-774

2022

Volltextzugriff (PDF)

Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression

Translational oncology, 2024-03, Vol.41, p.101869-101869, Article 101869

2024

Volltextzugriff (PDF)

Theranostic properties of a survivin-directed molecular beacon in human melanoma cells

PloS one, 2014-12, Vol.9 (12), p.e114588-e114588

2014

Volltextzugriff (PDF)

TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma

Frontiers in molecular biosciences, 2024-04, Vol.11, p.1288677-1288677

2024

Volltextzugriff (PDF)

Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs

Clinical pharmacokinetics, 2002, Vol.41 (6), p.431-444

2002

Volltextzugriff (PDF)

Clinical pharmacology of intravitreal anti-VEGF drugs

Eye (London), 2018-06, Vol.32 (6), p.1010-1020

2018

Volltextzugriff (PDF)

Opioid metabolism and drug-drug interaction in cancer

The oncologist (Dayton, Ohio), 2024-05

2024

Volltextzugriff (PDF)

Pharmacological insights on novel oral selective estrogen receptor degraders in breast cancer

European journal of pharmacology, 2024-04, Vol.969, p.176424-176424, Article 176424

2024

Volltextzugriff (PDF)

Sucrosomial® iron absorption studied by in vitro and ex-vivo models

European journal of pharmaceutical sciences, 2018-01, Vol.111, p.425-431

2018

Volltextzugriff (PDF)

Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs

Cancer treatment reviews, 2020-03, Vol.84, p.101966-101966, Article 101966

2020

Volltextzugriff (PDF)

Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer

Pharmacological reviews, 2003-03, Vol.55 (1), p.57-103

2003

Volltextzugriff (PDF)

Pharmacology differences among proteasome inhibitors: Implications for their use in clinical practice

Pharmacological research, 2021-05, Vol.167, p.105537, Article 105537

2021

Volltextzugriff (PDF)

Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer

Toxicology in vitro, 2018-10, Vol.52, p.243-250

2018

Volltextzugriff (PDF)

Drug-drug interactions in breast cancer patients treated with CDK4/6 inhibitors

Cancer treatment reviews, 2019-03, Vol.74, p.21-28

2019

Volltextzugriff (PDF)

Anticancer activity of anandamide in human cutaneous melanoma cells

European journal of pharmacology, 2013-10, Vol.718 (1-3), p.154-159

2013

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(127)

Publikationsform

Sprache

Englisch
(140)

Erscheinungsjahr

n.n

Thema

Science & Technology
(102)
Life Sciences & Biomedicine
(90)
Humans
(66)
Pharmacology & Pharmacy
(42)
Oncology
(29)
Biological And Medical Sciences
(20)
Female
(20)
Medical Sciences
(20)
Pharmacology. Drug Treatments
(18)
Animals
(17)
Antineoplastic Agents - Pharmacology
(16)
Male
(15)
Apoptosis
(14)
Cell Line, Tumor
(11)
Melanoma
(11)
Pharmacokinetics
(11)
Antineoplastic Agents
(10)
Apoptosis - Drug Effects
(10)
Breast Cancer
(10)
Cell Survival - Drug Effects
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Understanding the Mechanisms of Resistance in EGFR -Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy

The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide

Pathophysiology and pharmacological targets of VEGF in diabetic macular edema

Implications of KRAS mutations in acquired resistance to treatment in NSCLC

Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins

Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma

Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma

Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma

Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib

Abemaciclib pharmacology and interactions in the treatment of HR+/HER2- breast cancer: a critical review

Pharmacological Basis of Breast Cancer Resistance to Therapies - An Overview

Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression

Theranostic properties of a survivin-directed molecular beacon in human melanoma cells

TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma

Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs

Clinical pharmacology of intravitreal anti-VEGF drugs

Opioid metabolism and drug-drug interaction in cancer

Pharmacological insights on novel oral selective estrogen receptor degraders in breast cancer

Sucrosomial® iron absorption studied by in vitro and ex-vivo models

Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs

Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer

Pharmacology differences among proteasome inhibitors: Implications for their use in clinical practice

Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer

Drug-drug interactions in breast cancer patients treated with CDK4/6 inhibitors

Anticancer activity of anandamide in human cutaneous melanoma cells

Suchergebnisse filtern